NR 293 RUA Medication Teaching Plan Solved
Brochures can be used as a valuable educational tool to effectively educate a group of people. It can be used as an educational tool for patients regarding various conditions and medications that can be used to treat particular conditions or diseases. For example, a brochure can be used to convey important information regarding a particular medication, such as drug classification, side effects, drug interactions, patient education, and adverse effects, among others (Pakhchanian et al.,2020). Therefore, the formulated brochure has been designed to teach about current medication and explore various aspects of the medication.
The brochure is intended to serve as an educational tool regarding the use of Jesduvroq tablets in the treatment of anemia which is usually caused by chronic kidney disease in a patient who has been on dialysis. The intended audience for the education is 7th grade. The medication helps in reducing or avoiding the need to have red blood cell transfusions (Singh et al.,2021). Therefore, it is hoped that the brochure will be key in helping the targeted audience to have the required level of understanding regarding the medication. Of importance is to help the targeted audience know what needs to be done when a patient observes adverse effects, side effects, and possible drug interactions.
If the intended brochure audience has a low health literacy level, then it is necessary to revise the information so that it can fit the audience. First, it will be important to assess the audience to have an understanding of their actual literacy levels so that the material can be aligned as appropriate. One of the aspects or strategies to consider is the use of simple language that the audience will understand. For example, the side effects, drug interactions, and adverse effects will have to be written in simple language devoid of difficult medical terms.
References
Pakhchanian, H., Yuan, M., Raiker, R., Waris, S., & Geist, C. (2022, January). Readability analysis of the American society of ophthalmic plastic & reconstructive surgery patient educational brochures. In Seminars In Ophthalmology (Vol. 37, No. 1, pp. 77–82). Taylor & Francis. https://doi.org/10.1080/08820538.2021.1919721
Singh, A. K., Carroll, K., McMurray, J. J., Solomon, S., Jha, V., Johansen, K. L., … & Perkovic, V. (2021). Daprodustat for the treatment of anemia in patients not undergoing dialysis. New England Journal of Medicine, 385(25), 2313–2324. DOI: 10.1056/NEJMoa2113380
NR293_RUA_Medication_Teaching_Plan_Guidelines_V2.docx Revised: 4/2020 2
b. One Page Paper (15 points/15%)
• Describes intended brochure audience
• Describes intended use of brochure
• Includes
o Name
o Date
o Class
o Reference page
c. APA Format (5 points/5%)
• Includes no more than 3 unique errors with APA format (current ed.)
• At least two (2) scholarly, primary sources from the last 5 years, excluding the textbook, are provided
d. Writing and Mechanics (5 points/5%)
• Clearly written
• Includes no more than three unique errors of grammar
• Includes no more than three unique errors in writing mechanics
• Paper is one page, excluding references and title page
Medication Teaching Plan
Ocrelizumab, under the trade name OCREVUS, was approved by the FDA in 2017, and the European Commission in 2018 for the treatment of multiple sclerosis (MS) Primary progressive MS, in adults (Asher, 2018). The drug has been on the market for only 3 years. As such, it is necessary to develop a brochure to inform, publicize, and identify the new pharmacological agent. Most importantly, before developing the brochure, it very important to understand the target audience to which the message will be aiming.
The target audience in this case will consider several variables such as age group, gender, social status, and education
level among others. Given that the main indications for Oocrelizumab are the management of MS, then the brochure will focus on reaching individuals who are at high risk of this condition (Ornia, 2016). Such individuals include young adults between the age of 20 to 50 years, women (Three times as likely to get MS as men), people from the north European descent, and those who have a high smoking habit among others.
The main reason behind the development of the brochure, as mentioned earlier, will be to inform, publicize, and identify. The brochure will inform the public on all the necessary information regarding the new drug, such as its indications, mode of action, dosage, mode of administration, interactions, and side effects among others (Way, Blazsin, Löfstedt, & Bouder, 2017). It is also intended to make the drug known to the public, for its effectiveness in the management of MS. Lastly, the brochure is intended to promote the identity of the company which produced the drug.
Also Read: NR 449 RUA Topic Search Strategy Solved
ReferencesTop of FormTop of FormTop of Form
Asher, M. (2018). 2017 FDA drug approvals. Nature Reviews Drug Discovery, 17. https://doi.org/10.1038/nrd.2018.4
Ornia, G. F. (2016). Medical Brochure as a Textual Genre. Cambridge, UK: Cambridge Scholars Publishing.
Way, D., Blazsin, H., Löfstedt, R., & Bouder, F. (2017). Pharmaceutical benefit-risk communication tools: A review of the literature. Drug Safety, 40, 1, 15-36. DOI: 10.1007/s40264-016-0466-1
Ocrelizumab, under the trade name OCREVUS, was approved by the FDA in 2017, and the European Commission in 2018 for the treatment of multiple sclerosis (MS) Primary progressive MS, in adults (Asher, 2018). The drug has been on the market for only 3 years. As such, it is necessary to develop a brochure to inform, publicize, and identify the new pharmacological agent. Most importantly, before developing the brochure, it very important to understand the target audience to which the message will be aiming.
The target audience in this case will consider several variables such as age group, gender, social status, and education level among others. Given that the main indications for Oocrelizumab are the management of MS, then the brochure will focus on reaching individuals who are at high risk of this condition (Ornia, 2016). Such individuals include young adults between the age of 20 to 50 years, women (Three times as likely to get MS as men), people from the north European descent, and those who have a high smoking habit among others.
The main reason behind the development of the brochure, as mentioned earlier, will be to inform, publicize, and identify. The brochure will inform the public on all the necessary information regarding the new drug, such as its indications, mode of action, dosage, mode of administration, interactions, and side effects among others (Way, Blazsin, Löfstedt, & Bouder, 2017). It is also intended to make the drug known to the public, for its effectiveness in the management of MS. Lastly, the brochure is intended to promote the identity of the company which produced the drug.
References
Asher, M. (2018). 2017 FDA drug approvals. Nature Reviews Drug Discovery, 17. https://doi.org/10.1038/nrd.2018.4
Ornia, G. F. (2016). Medical Brochure as a Textual Genre. Cambridge, UK: Cambridge Scholars Publishing.
Way, D., Blazsin, H., Löfstedt, R., & Bouder, F. (2017). Pharmaceutical benefit-risk communication tools: A review of the literature. Drug Safety, 40, 1, 15-36. DOI: 10.1007/s40264-016-0466-1